Paris, France

Frederic Dublanchet



Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Frederic Dublanchet: Innovator in Content Protection Technology

Introduction

Frederic Dublanchet is a notable inventor based in Paris, France. He has made significant contributions to the field of content protection technology. His innovative approach focuses on the transmission and processing of protected content, which is crucial in today's digital landscape.

Latest Patents

Dublanchet holds a patent for a method of transmitting and storing scrambled content. This patent involves the transmission of scrambled content along with encrypted control words. The control words are essential for descrambling the content, ensuring that only authorized users can access it. The method also includes the transmission of usage rules messages that impose constraints on the playback of the content. This innovative approach enhances the security and management of digital content.

Career Highlights

Frederic Dublanchet is associated with Thomson Licensing S.A., where he has been instrumental in developing advanced content protection solutions. His work has positioned him as a key player in the industry, contributing to the evolution of secure content transmission methods.

Collaborations

Dublanchet has collaborated with notable colleagues such as David Leporini and Andre Surcouf. These partnerships have fostered innovation and have led to the development of cutting-edge technologies in the field of content protection.

Conclusion

Frederic Dublanchet's contributions to content protection technology highlight his role as an influential inventor. His patent for transmitting and processing protected content showcases his commitment to enhancing digital security. His work continues to impact the industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…